Skip to main content
LQDA logo

LQDA · Liquidia Corp

Track LQDA — free
Market Cap
$5.99B
Shares
89.51M

LQDA metrics

70 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$69.68
Market cap
$5.99B

Price action

19 metrics
Price change (1W)
-5.1%
Price change (30D)
-20.2%
Price change (3M)
+21.4%
Price change (6M)
+110.5%
Price change (YTD)
+94.0%
Price change (1Y)
+141.7%
Trailing year
Price change (5Y)
+2,289.6%
52-week high
$91.03
52-week low
$21.80
Change from 52-week high
-26.5%
Change from 52-week low
+206.9%
Annualized volatility
65.6%
Beta
0.9
RSI (14D)
35.6
Price vs SMA 50
-15.2%
Price vs SMA 200
+31.9%
Avg volume (3M)
1.89M
Relative volume
0.7
Average dollar volume
$141.28M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
89.51M

Valuation

12 metrics
P / E (TTM)
47.8
Trailing earnings · reciprocal yield 2.1%
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
13.3×
reciprocal yield 7.5%
P / book
30.7
reciprocal yield 3.3%
FCF yield
2.5%
TTM · current market cap
Buyback yield
P / FCF
39.7
reciprocal yield 2.5%
P / operating cash flow
35.7
reciprocal yield 2.8%
Earnings yield
2.3%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
21.2×
reciprocal yield 4.7%
EV / revenue historical average (5Y)
21.2×
reciprocal yield 4.7%
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
Operating margin
37.4%
Trailing 12 months
Net margin
30.7%
Gross profit (TTM)
Operating profit (TTM)
$168.57M
Net income (TTM)
$138.61M
Trailing 12 months
Diluted EPS (TTM)
$1.40
FCF margin
33.4%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$1.24

Growth

11 metrics
Revenue growth YoY
+1,842.7%
Year over year
Net income growth YoY
Revenue (TTM)
$450.91M
Trailing 12 months
EPS growth YoY
Shares change YoY
+18.5%
Year over year · more shares
Revenue CAGR (3Y)
+115.0%
Revenue CAGR (5Y)
+192.5%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
71.0%
Return on assets
26.6%
Debt / equity
Current ratio
2.3
EBITDA (TTM)
$170.25M
Free cash flow (TTM)
$150.69M
Quick ratio
2.1
Interest coverage
6.3
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$284.18M
Total assets
$521.92M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$167.71M
Capital expenditures (TTM)
$17.01M
R&D (TTM)
$56.04M
SG&A (TTM)
$192.66M
Stock compensation (TTM)
$34.69M
R&D / revenue
12.4%
Stock compensation / revenue
7.7%

Ownership (13F)

3 metrics
13F filers
340
13F filer change QoQ
+89
Institutional ownership
89.3%

Short interest

3 metrics
Short interest
13.2%
Latest settlement · 6.5 days to cover
Days to cover
6.5d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$120.38M
Insider-sentiment score
11 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1819576 CUSIP 53635D202 13F (30d) 267 filings 264 filers Visit website Investor relations